Cocrystal Pharma COCP
NASDAQ COCP
$1.16 +0.02 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Cash from Discontinued Operations (2012 - 2013)

Updated

Cocrystal Pharma (COCP) reported Cash from Discontinued Operations of -$2.51 million for Q4 2013, compared with $1.14 million a year earlier.

Analysis

Cocrystal Pharma (COCP) Cash from Discontinued Operations (2012 - 2013) Analysis & Trends

For FY2013, Cocrystal Pharma posted Cash from Discontinued Operations of -$2.49 million.

  • By year, Cash from Discontinued Operations came in at $1.13 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Cocrystal Pharma 16.00 Mn -5.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -2.51 Mn
Dec 31, 2012 1.14 Mn
API Access

Cocrystal Pharma Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=COCP&period=max&api_key=YOUR_API_KEY